Exploring Novel Tetrahydropyrimidine and Fused Pyrimidine‐Based Compounds as DHFR Inhibitors and Antimicrobial Agents: Synthesis, In Vitro, In Vivo, and In Silico Studies

Ähnliche Einträge

• Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors
  von: Sara Sultan, et al.
  Veröffentlicht: (2025)
• Greener Synthesis of Novel 1,2,3,4‐Tetrahydropyrimidine Derivatives Using Ionic Liquid for Targeting Plasmodium falciparum DHFR
  von: Shaffiqali Y. Saiyad, et al.
  Veröffentlicht: (2024)
• Multitargeted Anti‐Inflammatory Agents: Novel Pyrazole and Pyrazolo[1,5‐ a ]Pyrimidine Carbonic Anhydrase and COX‐2 Inhibitors With Optimal In Vivo Efficacy and Low Toxicity
  von: Mariam M. Fakhry, et al.
  Veröffentlicht: (2025)
• Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
  von: Marwa I. Serag, et al.
  Veröffentlicht: (2024)
• Highly Efficient One‐Pot Synthesis of New Theino[2,3‐ b ] Pyridine and Pyrimido[1,2‐ a ]Pyrimidine Scaffolds as Potential Antimicrobial Activity
  von: Najla Altwaijry, et al.
  Veröffentlicht: (2026)